Skip to main content

Table 1 Characteristics of women diagnosed with HIV, Israel, 2010–2018

From: HIV-1 infection among women in Israel, 2010–2018

  All years (2010–2018) N = 763 2010–2012 N = 246 2013–2015 N = 257 2016–2018 N = 260 p value
Median age at diagnosis (IQR) 38 (31–46) 37 (29–43) 37 (30–46) 40 (34–48) < 0.001
Place of birth, n (%)
 SSA 246 (32.2) 110 (44.7) 64 (24.9) 72 (27.7)  
 FSU 314 (41.2) 77 (31.3) 107 (41.6) 130 (50)  
 Israel 87 (11.4) 30 (12.2) 32 (12.5) 25 (9.6) < 0.001
 Other/Unknown 116 (15.2) 29 (11.8) 54 (21) 33 (12.7)  
Risk Groups, n (%)
 Sexual contact 629 (82.4) 202 (82.1) 211 (82.1) 216 (83.1)  
 IDU 83 (10.9) 34 (13.8) 33 (12.8) 16 (6.2) 0.001
 Other/Unknown 51 (6.7) 10 (4.1) 13 (5.1) 28 (10.8)  
HIV-1 Subtype (N) 337 123 109 105  
 A, n (%) 130 (38.6) 45 (36.6) 40 (36.7) 45 (42.9)  
 B, n (%) 34 (10.1) 10 (8.1) 17 (15.6) 7 (6.7)  
 C, n (%) 141 (41.8) 61 (49.6) 44 (40.4) 36 (34.3) 0.014
 G/AG, n (%) 23 (6.8) 3 (2.4) 7 (6.4) 13 (12.4)  
 Other, n (%) 9 (2.7) 4 (3.3) 1 (0.9) 4 (3.8)  
CD4 (cells/mm*3) (n = 171), median (IQR) 263 (121–466) 285 (146–496) 270 (133–492) 234 (73–394) 0.283
VL (Log c/mL) (n = 236), median (IQR) 4.5 (3.9–5.4) 4.4 (3.7–5.4) 4.6 (4.1–5.2) 4.8 (4.3–5.3) 0.519
  1. Data are presented as n (%) or median (IQR); IQR Interquartile range, VL Viral load, SSA Sub-Saharan Africa, FSU Former Soviet Union, IDU Injecting drug users.